Analytical methods, kit and detection devices
AssigneeKabushiki Kaisha Toshiba
InventorsTakuya MIYAGAWA, Yoshitake SANO, Tomomi TAKAHASHI, Mitsuko ISHIHARA
Life of this patent
Estimating the term…
Abstract
According to one embodiment, analytical methods and kits are provided for determining the probability that a subject has breast cancer, pancreatic cancer, lung cancer, gastric cancer, or colorectal cancer. The analytical methods include quantifying a target miRNA selected from a group of target miRNAs in a sample derived from the subject to be analyzed.
Claims33
An analytical method including:
- quantifying a miRNA selected from the group consisting of hsa-miR-128-3p, hsa-miR-151a-3p, hsa-miR-143-3p, hsa-miR-4770, hsa-miR-1296-5p, hsa-miR-125a-5p, hsa-miR-409-3p, hsa-miR-99a-5p and hsa-miR-215-5p in a subject, and
- determining a probability that the subject has breast cancer, pancreatic cancer, lung cancer, gastric cancer, or colorectal cancer.
An analytical method including:
- quantifying a miRNA selected from the group consisting of hsa-miR-128-3p, hsa-miR-151a-3p, hsa-miR-143-3p, hsa-miR-4770, hsa-miR-125a-5p and hsa-miR-99a-5p in a subject, and
- determining a probability that the subject has breast cancer.
An analytical method including:
- quantifying a miRNA selected from the group consisting of hsa-miR-126-3p, hsa-miR-326, hsa-miR-28-3p, hsa-miR-425-3p, hsa-miR-93-3p, hsa-miR-24-3p, hsa-miR-222-3p, hsa-miR-361-5p and hsa-miR-342-3p in a subject, and
- determining a probability that the subject has breast, pancreatic or colorectal cancer.
An analytical method, including:
- quantifying a miRNA selected from the group consisting of hsa-miR-126-3p, hsa-miR-326, hsa-miR-28-3p, hsa-miR-425-3p, hsa-miR-93-3p, hsa-miR-24-3p, hsa-miR-222-3p, hsa-miR-361-5p, hsa-miR-342-3p and hsa-miR-10b-5p in a subject, and
- determining a possibility that the subject has colorectal cancer.
A kit for determining the probability that the subject has breast, pancreatic, lung, gastric and colorectal cancer, comprising at least one nucleic acid set that specifically binds to a miRNA selected from the group consisting of hsa-miR-128-3p, hsa-miR-151a-3p, hsa-miR-143-3p, hsa-miR-4770, hsa-miR-1296-5p, hsa-miR-125a-5p, hsa-miR-409-3p, hsa-miR-99a-5p and hsa-miR-215-5p.
Dependencies are inferred from the claim text.